- Home
- OBIO vs LFCR Comparison
OBIO vs LFCR Comparison
Compare OBIO & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- LFCR
- Stock Information
- Founded
- OBIO 2017
- LFCR 1986
- Country
- OBIO United States
- LFCR United States
- Employees
- OBIO N/A
- LFCR N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- OBIO Health Care
- LFCR Health Care
- Exchange
- OBIO Nasdaq
- LFCR Nasdaq
- Market Cap
- OBIO 200.1M
- LFCR 164.3M
- IPO Year
- OBIO N/A
- LFCR N/A
- Fundamental
- Price
- OBIO $5.84
- LFCR $6.40
- Analyst Decision
- OBIO Strong Buy
- LFCR Buy
- Analyst Count
- OBIO 4
- LFCR 2
- Target Price
- OBIO $15.75
- LFCR $8.00
- AVG Volume (30 Days)
- OBIO 57.1K
- LFCR 174.3K
- Earning Date
- OBIO 11-12-2024
- LFCR 10-04-2024
- Dividend Yield
- OBIO N/A
- LFCR N/A
- EPS Growth
- OBIO N/A
- LFCR N/A
- EPS
- OBIO N/A
- LFCR 0.17
- Revenue
- OBIO $2,647,000.00
- LFCR $128,443,999.00
- Revenue This Year
- OBIO $7.68
- LFCR $2.23
- Revenue Next Year
- OBIO $110.40
- LFCR $8.40
- P/E Ratio
- OBIO N/A
- LFCR $44.60
- Revenue Growth
- OBIO N/A
- LFCR 23.42
- 52 Week Low
- OBIO $4.22
- LFCR $3.68
- 52 Week High
- OBIO $11.69
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- OBIO 51.19
- LFCR 58.32
- Support Level
- OBIO $5.56
- LFCR $5.56
- Resistance Level
- OBIO $6.50
- LFCR $7.23
- Average True Range (ATR)
- OBIO 0.53
- LFCR 0.35
- MACD
- OBIO 0.00
- LFCR 0.04
- Stochastic Oscillator
- OBIO 56.58
- LFCR 51.18
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.